Global Diabetic Neurological Disorder Therapeutic Drug Market Research Report 2024

Diabetic Neurological Disorder Therapeutic Drug Market

A drug used to treat mental illness caused by diabetes

The global Diabetic Neurological Disorder Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Diabetic Neurological Disorder Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Neurological Disorder Therapeutic Drug.

Report Scope

The Diabetic Neurological Disorder Therapeutic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Neurological Disorder Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetic Neurological Disorder Therapeutic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

AstraZeneca

Johnson & Johnson

Takeda

Mitsubishi Chemical

Avanir Pharmaceuticals

Dong-A Pharmaceutical Co., Ltd.

Immune Pharmaceuticals

MediciNova

Sangamo BioSciences

Capsule

Pills

Other

Symmetrical Neuropathy

Focal and Multifocal Neuropathy

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Scope of Diabetic Neurological Disorder Therapeutic Drug Market Report

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diabetic Neurological Disorder Therapeutic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Capsule

1.2.3 Pills

1.2.4 Other

1.3 Market by Application

1.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Symmetrical Neuropathy

1.3.3 Focal and Multifocal Neuropathy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2019-2030)

2.2 Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Region

2.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Region (2019-2024)

2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2025-2030)

2.3 Diabetic Neurological Disorder Therapeutic Drug Market Dynamics

2.3.1 Diabetic Neurological Disorder Therapeutic Drug Industry Trends

2.3.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers

2.3.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges

2.3.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints

3.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue

3.1.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue (2019-2024)

3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2019-2024)

3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue

3.4 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio

3.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2023

3.5 Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Area Served

3.6 Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service

3.7 Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2019-2024)

4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2025-2030)

5.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Application (2019-2024)

5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2025-2030)

6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

6.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

8.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

9.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

9.4 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)

10.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 AstraZeneca

11.1.1 AstraZeneca Company Detail

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction

11.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.1.5 AstraZeneca Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction

11.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Takeda

11.3.1 Takeda Company Detail

11.3.2 Takeda Business Overview

11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction

11.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.3.5 Takeda Recent Development

11.4 Mitsubishi Chemical

11.4.1 Mitsubishi Chemical Company Detail

11.4.2 Mitsubishi Chemical Business Overview

11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction

11.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.4.5 Mitsubishi Chemical Recent Development

11.5 Avanir Pharmaceuticals

11.5.1 Avanir Pharmaceuticals Company Detail

11.5.2 Avanir Pharmaceuticals Business Overview

11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction

11.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.5.5 Avanir Pharmaceuticals Recent Development

11.6 Dong-A Pharmaceutical Co., Ltd.

11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Detail

11.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview

11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction

11.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Development

11.7 Immune Pharmaceuticals

11.7.1 Immune Pharmaceuticals Company Detail

11.7.2 Immune Pharmaceuticals Business Overview

11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction

11.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.7.5 Immune Pharmaceuticals Recent Development

11.8 MediciNova

11.8.1 MediciNova Company Detail

11.8.2 MediciNova Business Overview

11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction

11.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.8.5 MediciNova Recent Development

11.9 Sangamo BioSciences

11.9.1 Sangamo BioSciences Company Detail

11.9.2 Sangamo BioSciences Business Overview

11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction

11.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

11.9.5 Sangamo BioSciences Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Capsule

    Table 3. Key Players of Pills

    Table 4. Key Players of Other

    Table 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)

    Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2019-2024)

    Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2025-2030)

    Table 11. Diabetic Neurological Disorder Therapeutic Drug Market Trends

    Table 12. Diabetic Neurological Disorder Therapeutic Drug Market Drivers

    Table 13. Diabetic Neurological Disorder Therapeutic Drug Market Challenges

    Table 14. Diabetic Neurological Disorder Therapeutic Drug Market Restraints

    Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024) & (US$ Million)

    Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players (2019-2024)

    Table 17. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2023)

    Table 18. Ranking of Global Top Diabetic Neurological Disorder Therapeutic Drug Companies by Revenue (US$ Million) in 2023

    Table 19. Global 5 Largest Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue (CR5 and HHI) & (2019-2024)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service

    Table 22. Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)

    Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2019-2024)

    Table 26. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 27. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2025-2030)

    Table 28. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)

    Table 29. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Application (2019-2024)

    Table 30. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 31. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Application (2025-2030)

    Table 32. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 33. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 34. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 35. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 36. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 37. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 38. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 39. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)

    Table 40. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2025-2030) & (US$ Million)

    Table 41. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 42. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 43. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 44. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 45. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)

    Table 46. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)

    Table 47. AstraZeneca Company Detail

    Table 48. AstraZeneca Business Overview

    Table 49. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product

    Table 50. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 51. AstraZeneca Recent Development

    Table 52. Johnson & Johnson Company Detail

    Table 53. Johnson & Johnson Business Overview

    Table 54. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product

    Table 55. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 56. Johnson & Johnson Recent Development

    Table 57. Takeda Company Detail

    Table 58. Takeda Business Overview

    Table 59. Takeda Diabetic Neurological Disorder Therapeutic Drug Product

    Table 60. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 61. Takeda Recent Development

    Table 62. Mitsubishi Chemical Company Detail

    Table 63. Mitsubishi Chemical Business Overview

    Table 64. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product

    Table 65. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 66. Mitsubishi Chemical Recent Development

    Table 67. Avanir Pharmaceuticals Company Detail

    Table 68. Avanir Pharmaceuticals Business Overview

    Table 69. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product

    Table 70. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 71. Avanir Pharmaceuticals Recent Development

    Table 72. Dong-A Pharmaceutical Co., Ltd. Company Detail

    Table 73. Dong-A Pharmaceutical Co., Ltd. Business Overview

    Table 74. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product

    Table 75. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 76. Dong-A Pharmaceutical Co., Ltd. Recent Development

    Table 77. Immune Pharmaceuticals Company Detail

    Table 78. Immune Pharmaceuticals Business Overview

    Table 79. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product

    Table 80. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 81. Immune Pharmaceuticals Recent Development

    Table 82. MediciNova Company Detail

    Table 83. MediciNova Business Overview

    Table 84. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product

    Table 85. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 86. MediciNova Recent Development

    Table 87. Sangamo BioSciences Company Detail

    Table 88. Sangamo BioSciences Business Overview

    Table 89. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product

    Table 90. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)

    Table 91. Sangamo BioSciences Recent Development

    Table 92. Research Programs/Design for This Report

    Table 93. Key Data Information from Secondary Sources

    Table 94. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2023 VS 2030

    Figure 3. Capsule Features

    Figure 4. Pills Features

    Figure 5. Other Features

    Figure 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2023 VS 2030

    Figure 8. Symmetrical Neuropathy Case Studies

    Figure 9. Focal and Multifocal Neuropathy Case Studies

    Figure 10. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered

    Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region: 2023 VS 2030

    Figure 14. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2023

    Figure 15. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2023)

    Figure 16. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2023

    Figure 17. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 18. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

    Figure 19. United States Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 20. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

    Figure 23. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 24. France Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2019-2030)

    Figure 31. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 32. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

    Figure 39. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 40. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)

    Figure 43. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 44. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 46. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 47. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 48. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 49. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 50. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 51. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 52. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 53. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed